Filter
2842
Text search:
recommendation
Featured
Recommendations
300
New Publications
679
Language
Document type
No document type
1511
Guidelines
572
Studies & Reports
400
Manuals
144
Strategic & Response Plan
72
Fact sheets
65
Training Material
46
Situation Updates
18
Resource Platforms
5
Brochures
4
Infographics
2
Videos
2
Online Courses
1
Countries / Regions
India
154
Global
139
Western and Central Europe
62
Nepal
59
Kenya
54
South Africa
49
Nigeria
45
Uganda
45
Sierra Leone
42
Latin America and the Carribbean
39
Tanzania
37
Myanmar / Burma
37
Ethiopia
36
Bangladesh
35
Africa
34
Zambia
31
Philippines
28
Namibia
28
Liberia
27
Rwanda
25
Malawi
24
Ghana
21
Zimbabwe
21
Indonesia
21
Eastern Europe
20
Ukraine
18
Syria
17
Mozambique
17
Brazil
17
Congo, Democratic Republic of
16
Germany
15
South–East Asia Region
15
Lesotho
13
Asia
12
Russia
12
Guinea
11
Burkina Faso
11
Senegal
11
South Sudan
11
West and Central Africa
11
Middle East and North Africa
11
East and Southern Africa
10
Eastern Europe and Central Asia
10
Cambodia
9
Cameroon
8
Haiti
8
Pakistan
8
Eswatini/ Swaziland
8
Afghanistan
7
Botswana
7
USA
6
Colombia
6
Vietnam
6
Mali
5
Madagascar
5
Yemen
5
Western Pacific Region
5
Côte d’Ivoire / Ivory Coast
4
Jordan
4
Thailand
4
Sudan
4
Angola
4
Venezuela
4
Albania
4
Laos
4
Tajikistan
4
Kazakhstan
4
Iraq
3
Turkey
3
Benin
3
Peru
3
Greece
3
Sri Lanka
3
Bhutan
3
Poland
3
Georgia
3
United Kingdom
3
Guinea-Bissau
2
Niger
2
Somalia
2
Central African Republic
2
Argentina
2
Hungary
2
Ecuador
2
Armenia
2
Iran
2
Kyrgyzstan
2
North America
2
Portugal
2
Spain
2
Belarus
2
Egypt
1
Chad
1
Gambia
1
China
1
Malaysia
1
Mauritania
1
Ireland
1
Singapore
1
Vanuatu
1
Burundi
1
El Salvador
1
Bolivia
1
Other region
1
Paraguay
1
Fiji
1
Italy
1
Southern Africa
1
Timor Leste/ East Timor
1
Bulgaria
1
Estonia
1
Lithuania
1
Uzbekistan
1
Japan
1
Denmark
1
South Korea
1
Israel
1
Bosnia and Herzegovina
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
889
Clinical Guidelines
340
Women & Child Health
229
Public Health
142
Key Resources
134
Capacity Building
47
Pharmacy & Technologies
32
Toolboxes
HIV
317
COVID-19
247
Mental Health
206
TB
179
NTDs
89
Caregiver
81
Disability
79
AMR
72
NCDs
71
Malaria
65
Ebola & Marburg
55
Planetary Health
55
Rapid Response
49
Refugee
47
Pharmacy
44
Conflict
40
Health Financing Toolbox
26
Polio
24
Global Health Education
24
2.0 Rapid Response
23
Natural Hazards
19
Specific Hazards
18
Zika
17
Cholera
14
Social Ethics
7
Typhoon
2
South Sudan
1
Asthma is a heterogeneous condition characterised by chronic inflammation and variable expiratory airflow limitation, with airway reversibility. Management of chronic inflammation with anti-asthma medication improves asthma control and quality of life. The aim of this journal is to provide an eviden
...
The South African (SA) guidelines for cardiac patients for non-cardiac surgery were developed to address the need for cardiac risk assessment and risk stratification for elective non-cardiac surgical patients in SA, and more broadly in Africa.
The guidelines were developed by updating the Canadian
...
Asthma is a heterogeneous condition characterised by chronic inflammation and variable expiratory airflow limitation, as well as airway reversibility. The diagnosis of asthma in young children is limited by the inability to perform objective lung function testing in this group of patients and the wi
...
The Infection prevention and control in the context of coronavirus disease 2019 (COVID-19): a living guideline consolidates technical guidance developed and published during the COVID-19 pandemic into evidence-informed recommendations for infection prevention and control (IPC). This living guideline
...
COVIBOOK
recommended
#COVIBOOK-Supporting and reassuring children around the world
This short book is created to support and reassure our children, under the age of 7, regarding the COVID-19. This book is an invitation for families to discuss the full range of emotions arising from the current situation. It is importa
...
These WHO guidelines which were updated in 2018, are valid for any country and suitable to local adaptations, and take account of the strength of available scientific evidence, the cost and resource implications, and patient values and preferences.
The 2018 edition of the guidelines includes the re
...
Interim Guidance October 2022. This addendum addresses some of the methodological aspects of VE evaluations that have been learned during the past year, as well as those that have become relevant in the current epidemiological setting of the COVID-19 pandemic. For some of the COVID-19 vaccine method
...
This treatment guideline is intended to assist clinicians in the Behavioral Health department in treatment planning and service delivery for patients with Post Traumatic Stress Disorder (PTSD). It may also assist clinicians treating patients who have some of the signs and symptoms of PTSD but who do
...
BACKGROUND. Asthma is a heterogeneous condition characterised by chronic inflammation and variable expiratory airflow limitation, as well as airway reversibility. The burden of asthma in children is increasing in low- and middle-income countries and remains under-recognised and poorly managed.
OBJE
...
WHO Living guideline: Drugs to prevent COVID-19
recommended
Interim guidance 2 march 2021
Current use of drugs to prevent COVID-19 is variable, reflecting large-scale uncertainty. Numerous randomized trials of many different drugs are underway to inform practice. This first version of the Drugs to prevent COVID-19: A WHO living guideline contains new inform
...
“Guide to facilitate the implementation of the WHO/UNICEF “Guidance on developing a national deployment and vaccination plan for COVID-19 vaccines” for Africa
t contains action-oriented lists of critical topics to address and checklists tailored to the context of African Union Member States.
...
Updated 2022. This guide addresses the care pathway from presentation of the patient to a health facility to patient discharge. It considers different levels of disease severity, from asymptomatic individuals to critically ill patients. Accounting for variations in the benefits and harms of chest im
...
The 10 recommendations in the COP26 Special Report on Climate Change and Health propose a set of priority actions from the global health community to governments and policy makers, calling on them to act with urgency on the current climate and health crises.
The recommendations were developed in
...
2nd edition. These guidelines include several notable changes from the first edition. For cutaneous leishmaniasis, ketoconazole has been removed from the list of treatment options; the number of Leishmania species for which there is strong evidence for the efficacy of miltefosine has increased from
...
In 2014, an estimated 40 million women of reproductive age were infected with Schistosoma haematobium, S. japonicum and/or S. mansoni. In both 2003 and 2006, the World Health Organization (WHO) recommended that all schistosome-infected pregnant and breastfeeding women be offered treatment, with praz
...
Yaws is targeted for eradication by 2030, using a strategy based on mass drug administration (MDA) with azithromycin. New diagnostics are needed to aid eradication. Serology is currently the mainstay for yaws diagnosis; however, inaccuracies associated with current serological tests makes it difficu
...
This practical manual is designed to support implementation of the World Health Organization (WHO) Guidelines on core components of infection prevention and control programmes at the national level, with special focus on countries with limited resources.
The Guidelines describe what is necessary
...
African countries, like many regions of the world, are affected by the legacy of atrocity crimes. Genocide, the transatlantic slave trade and slavery, colonialism and post-independence violence committed during dictatorships, not to mention civil war and violent extremism, have severely violated hum
...
Interim guidance, 26 October 2021
This interim guidance has been developed on the basis of the advice issued by the Strategic Advisory Group of Experts (SAGE) on Immunization at its meeting on 5 October 2021.
SAGE said moderately and severely immunocompromised persons should be offered an addition
...
